October 4-5, 2018, UCLA California NanoSystems Institute
Symposium Agenda: Thursday, October 4, 2018
| 9:00 am – 10:00 am |
Breakfast & Registration |
|
| 10:00 am – 10:10 am |
Welcome & Introductory Remarks |
Jeff F. Miller (UCLA) & Robert Damoiseaux (UCLA) |
| 10:10 am – 10:30 am |
UC-DDC: Overview |
Joe Wagner (UC DDC): An Overview of the UC Drug Discovery Consortium |
| 10:30 am – 11:15 am |
UC Keynote |
Kevan Shokat (UCSF): Chemical Tricks for Drugging the Undruggable: Discovery and development of the first K-Ras inhibitor |
| 11:15 am – 12:00 pm |
UC Keynote |
Douglas Black (UCLA): Screening for Modulators of Alternative Pre-mRNA Splicing |
| 12:00 pm – 1:00 pm |
Lunch & Posters |
|
| 1:00 pm – 1:30 pm |
UC Keynote |
John MacMillan (UCSC): Natural Product-based Drug Discovery |
| 1:30 pm – 2:15 pm |
UC Keynote |
Daniele Piomelli (UCI): Targeting lipid signaling pathways for drug discovery |
| 2:15 pm – 3:00 pm |
UC Keynote |
Elizabeth Winzeler (UCSD): Phenotypic screening and cheminformatics in the search for next generation medicines for malaria |
| 3:00 pm – 3:15 pm |
Coffee Break |
|
| 3:15 pm – 3:40 pm |
DDC Seed Grant Recipient |
Gino Cortopassi (UCD): 3D Scaffold hopping to identify novel Shc inhibitors |
| 3:40 pm – 4:05 pm |
DDC Seed Grant Recipient |
Peter Bowers (UCLA): Development of Pleiotrophin Monoclonal Antibodies Targeting Leukemic Stem Cell Growth |
| 4:05 pm – 4:30 pm |
DDC Seed Grant Recipient |
Alessandra Franco (UCSD): Immune modulatory peptides derived from the heavy constant region of immunoglobulins that activate human natural regulatory T cells |
| 4:30 pm – 6:15 pm |
Oral Presentations, Posters & Reception |
|
Symposium Agenda: Friday, October 5, 2018
| 8:00 am – 9:00 am |
Breakfast & Registration |
|
| 9:00 am – 10:00 am |
UC-DDC Executive Committee |
Funding Opportunities; Mechanisms for Centrally Leveraging UC-Wide Assets; UC-Wide Institutional Knowledge for Acceleration of Drug Discovery |
| 10:00 am – 10:30 am |
UC Keynote |
Bruce Hammock (UC Davis): Soluble epoxide hydrolase inhibitors to the clinic with blueprint and on to treating Parkinson’s and other cns disorders |
| 10:30 am – 11:00 am |
UC Keynote |
Daniela Kaufer (UCB): Vascular dysfunction as a common driver of neuropathology in the aged and injured brain: A tale of translational study |
| 11:00 am – 11:30 pm |
UC Keynote |
Maurizio Pellecchia (UCR): The UCR Center for Molecular and Translational Medicine: Challenges, Opportunities, and Success Stories |
| 11:30 am – 11:45 am |
UC-DDC Education Programs |
Haim Weizman (UC-DDC Lead for Education): UC-DDC Education Programs Overview |
| 12:00 pm – 1:00 pm |
Lunch & Posters |
|
| 1:00 pm – 1:15 pm |
Trends in California Drug Discovery and Development |
Simone Fishburn (BioCentury and BioCentury Innovations) |
| 1:15 pm – 1:30 pm |
Trends in California Drug Discovery and Development |
Maria Millan (California Institute for Regenerative Medicine) |
| 1:30 pm – 1:45 pm |
Trends in California Drug Discovery and Development |
Mary Faris (Pfizer): Leveraging Internal Expertise and External Innovation towards Drug Discovery |
| 1:45 pm |
Closing Remarks & Wrap-Up |
|
